<DOC>
	<DOCNO>NCT00780377</DOCNO>
	<brief_summary>Heart transplant recipient nerve heart . This protocol test hypothesis bradykinin mediate t-PA release coronary artery reduce heart transplant recipient compare healthy subject . This study compare heart transplant recipient healthy control undergoing cardiac cath standard care purpose ( separate protocol ) compare coronary artery forearm transplant recipient ( separate protocol ) healthy control ( separate protocol ) .</brief_summary>
	<brief_title>Intracoronary Bradykinin Mediated t-PA Release Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<criteria>Inclusion criterion : 1 . Heart transplant recipient undergo annual cardiac catheterization participate protocol : Characterization brachial arterial tPA release , vasodilator function , vascular compliance correlation fibrinolytic balance , oxidative stress , inflammation measure heart transplant recipient ( SCCOR Project 1 , Aim 3C ) . ( IRB # 070517 ) 2 . 25 Subjects transplant vasculopathy 25 subject free transplant vasculopathy , document previous angiogram . 3 . Otherwise healthy Exclusion criterion : 1 . PVC &lt; 30 2 . Hypertensive subject ACE inhibitor 3 . Pregnant nursing mother 4 . Diabetic HbA1C &gt; 7.5 stigma end organ damage ( neuropathy , retinopathy , nephropathy , cardiomyopathy ) 5 . Cholesterol &gt; 30 mg/dL NCEP accept level base cardiac risk . 6 . Triglycerides &gt; 200 7 . Previously diagnose obstructive coronary artery disease 8 . Renal insufficiency ( Creatinine ≥ 1.5 mg/dl ) 9 . History cerebrovascular disease 10 . Any chronic inflammatory disease ( rheumatologic , inflammatory bowel disease , etc ) 11 . Uncontrolled Stage 2 Hypertension ( 160/100 mmHg ) , end organ damage due hypertension ( left ventricular hypertrophy , atrial fibrillation , hematuria , renal insufficiency , prior cerebrovascular disease ) . 12 . Angiotensin convert enzyme inhibitor use 13 . Coagulopathy ( INR ≥ 1.5 , PTT ≥ 150 % control ) 14 . Peripheral Vascular Disease 15 . Other chronic medical illness discretion investigator Healthy control enrolled SCCOR Project 1 , Aims 3A 3B ( IRB # 030473 061160 ) participate IRB number .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart Transplant</keyword>
	<keyword>Fibrinolysis</keyword>
	<keyword>Resting condition</keyword>
</DOC>